ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Clinuvel Pharmaceuticals Ltd (PK)

Clinuvel Pharmaceuticals Ltd (PK) (CLVLY)

7,275
0,385
(5,59%)
Fermé 15 Janvier 10:00PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
7,275
Prix Achat
7,04
Prix Vente
7,35
Volume échangé
2 702
7,115 Fourchette du Jour 7,275
6,80 Plage de 52 semaines 11,40
Cap du marché
Clôture Veille
6,89
Ouverture
7,115
Dernière Transaction
1
@
7.35
Dernière heure de transaction
Volume financier
US$ 19 361
VWAP
7,1653
Volume moyen (3 m)
3 553
Actions en circulation
50 127 270
Rendement du Dividende
0.41%
Ratio Cours sur Bénéfices
16,51
Bénéfice par action (BPA)
0,71
Chiffre d'affairess
88,74M
Bénéfice net
35,64M

À propos de Clinuvel Pharmaceuticals Ltd (PK)

Secteur
Medicinal Chems,botanicl Pds
Industrie
Drugs-health R&d/testing Labs
Site Web
Siège social
Melbourne, Victoria, Aus
Fondé
2000
Clinuvel Pharmaceuticals Ltd (PK) est coté dans le secteur Medicinal Chems,botanicl Pds de la OTCMarkets avec le ticker CLVLY. Le dernier cours de clôture d'Clinuvel Pharmaceuticals (PK) était de US$6,89. Au cours de la dernière année, les actions de Clinuvel Pharmaceuticals (PK) ont été négociées dans une fourchette de prix de US$ 6,80 à US$ 11,40.

Clinuvel Pharmaceuticals (PK) compte actuellement 50 127 270 actions en circulation. La capitalisation boursière d'Clinuvel Pharmaceuticals (PK) est de US$345,38 million. Clinuvel Pharmaceuticals (PK) a un ratio cours/bénéfice (ratio PE) de 16.51.

CLVLY Dernières nouvelles

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free exposure following the treatment of the 'orphan...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.038-0.5196225899087.3137.336.8127376.98777545DR
4-0.725-9.0625886.848087.24328651DR
12-1.755-19.43521594689.039.796.835538.05543316DR
26-2.965-28.95507812510.2410.76.827268.63368319DR
52-2.975-29.024390243910.2511.46.830779.21799878DR
156-10.965-60.115131578918.2419.986.8496612.33740719DR
260-12.725-63.6252031.446.8611315.07297097DR

CLVLY - Frequently Asked Questions (FAQ)

What is the current Clinuvel Pharmaceuticals (PK) share price?
The current share price of Clinuvel Pharmaceuticals (PK) is US$ 7,275
How many Clinuvel Pharmaceuticals (PK) shares are in issue?
Clinuvel Pharmaceuticals (PK) has 50 127 270 shares in issue
What is the market cap of Clinuvel Pharmaceuticals (PK)?
The market capitalisation of Clinuvel Pharmaceuticals (PK) is USD 345,38M
What is the 1 year trading range for Clinuvel Pharmaceuticals (PK) share price?
Clinuvel Pharmaceuticals (PK) has traded in the range of US$ 6,80 to US$ 11,40 during the past year
What is the PE ratio of Clinuvel Pharmaceuticals (PK)?
The price to earnings ratio of Clinuvel Pharmaceuticals (PK) is 16,51
What is the cash to sales ratio of Clinuvel Pharmaceuticals (PK)?
The cash to sales ratio of Clinuvel Pharmaceuticals (PK) is 6,63
What is the reporting currency for Clinuvel Pharmaceuticals (PK)?
Clinuvel Pharmaceuticals (PK) reports financial results in AUD
What is the latest annual turnover for Clinuvel Pharmaceuticals (PK)?
The latest annual turnover of Clinuvel Pharmaceuticals (PK) is AUD 88,74M
What is the latest annual profit for Clinuvel Pharmaceuticals (PK)?
The latest annual profit of Clinuvel Pharmaceuticals (PK) is AUD 35,64M
What is the registered address of Clinuvel Pharmaceuticals (PK)?
The registered address for Clinuvel Pharmaceuticals (PK) is LEVEL 11, 535 BOURKE STREET, MELBOURNE, VICTORIA, 3000
What is the Clinuvel Pharmaceuticals (PK) website address?
The website address for Clinuvel Pharmaceuticals (PK) is www.clinuvel.com
Which industry sector does Clinuvel Pharmaceuticals (PK) operate in?
Clinuvel Pharmaceuticals (PK) operates in the DRUGS-HEALTH R&D/TESTING LABS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDRSFRDARS Inc (CE)
US$ 0,001
(99 900,00%)
2,08k
DMTKQDermTech Inc (CE)
US$ 0,0005
(49 900,00%)
2k
COUVCorporate Universe Inc (CE)
US$ 0,0001
(9 900,00%)
2k
RQHTFReliq Health Technologies Inc (CE)
US$ 0,01
(9 900,00%)
63,14k
CLTHClean Tech Biofuels Inc (CE)
US$ 0,0001
(9 900,00%)
1 000
BLIBQBB Liquidating Inc (CE)
US$ 0,000001
(-99,99%)
21,08k
FLESAuto Parts 4Less Group Inc (CE)
US$ 0,000001
(-99,50%)
2,5M
DNAXDNA Brands Inc (PK)
US$ 0,000001
(-99,50%)
12,3M
FBECFBEC Worldwide Inc (CE)
US$ 0,000001
(-99,50%)
130k
CCTLCoin Citadel (PK)
US$ 0,000001
(-99,50%)
1,25k
TONRTonner One World Holdings Inc (PK)
US$ 0,0002
(0,00%)
331,58M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
292,68M
RDARRaadr Inc (PK)
US$ 0,00115
(-4,17%)
257,02M
TSOITherapeutic Solutions International Inc (PK)
US$ 0,0002
(0,00%)
253,17M
HMBLHUMBL Inc (PK)
US$ 0,001
(11,11%)
232,5M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock